Feb 28 (Reuters) - Wellnex Life Ltd WNX.AX:
REVENUE AND MARGIN GROWTH EXPECTED TO CONTINUE IN 2H FY25
LEVEL OF TRADE SPEND FOR 2H FY25 WILL REDUCE AS PERCENTAGE OF REVENUE AS WILL OPERATIONAL EXPENSES
TARGET OF ACHIEVING POSITIVE EBITDA IN H2 FY25
Further company coverage: WNX.AX
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.